TP53 and idiopathic pulmonary fibrosis: In summary, these data suggest that up-regulation of miR-34 miRNAs in IPF type II AECs, possibly driven by p53 activation, leads to down-regulation of key targets involved in the cell cycle leading to a senescent phenotype in these cells (Fig 7).